December 7, 2020
PAR-20-039 - Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)
NOT-GM-21-003 - Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence (SuRE)
NOT-GM-21-008 - Notice of Intent to Publish a Funding Opportunity Announcement for Support for Research Excellence - First Independent Research Support & Transition (SuRE-First)
NOT-GM-21-009 - Notice of Intent to Publish a Funding Opportunity Announcement for Regional Coordinating Center for the Support for Research Excellence (SuRE) Program
National Institute of General Medical Sciences (NIGMS)
The purpose of this Notice is to alert potential applicants to the early expiration of PAR-20-039 "Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)." This FOA will expire on May 8, 2021.
The FOA has been updated accordingly.
Part 1. Key Dates
The FOA currently reads:
Application Due Date(s)
January 25, 2020; May 25, 2020; January 25, 2021; May 25, 2021; January 25, 2022; May 25, 2022
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
May 7, 2020; September 7, 2020; May 7, 2021; September 7, 2021; May 7, 2022 and September 7, 2022
All applications are due, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date
Scientific Merit Review
July 2020, November 2020, July 2021, November 2021, July 2022, November 2022
Advisory Council Review
October 2020, January 2021, October 2021, January 2022, October 2022, January 2023
Earliest Start Date
January 2021, April 2021, January 2022, April 2022, January 2023, April 2023
Expiration Date
September 8, 2022
The FOA is modified to read:
Application Due Date(s)
January 25, 2020; May 25, 2020; January 25, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s)
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
May 7, 2020; September 7, 2020; May 7, 2021
All applications are due, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s).
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
July 2020, November 2020, July 2021
Advisory Council Review
October 2020, January 2021, October 2021
Earliest Start Date
January 2021, April 2021, January 2022
Expiration Date
May 8, 2021
All other aspects of this FOA remain unchanged
Irina N. Krasnova, Ph.D.
National Institute of General Medical Sciences (NIGMS)
Email: [email protected]